202 related articles for article (PubMed ID: 38555474)
1. D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer.
Shi Y; Li C; Zhang X; Peng C; Sun P; Zhang Q; Wu L; Ding Y; Xie D; Xu Z; Zhu W
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38555474
[TBL] [Abstract][Full Text] [Related]
2. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.
Zhao D; Zhao Y; He S; Liu Z; Li K; Zhang L; Zhang X; Wang S; Che N; Jin M
BMC Pulm Med; 2023 Jul; 23(1):244. PubMed ID: 37407963
[TBL] [Abstract][Full Text] [Related]
3. A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Lu CF; Liao CY; Chao HS; Chiu HY; Wang TW; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
Cancer Imaging; 2023 Jan; 23(1):9. PubMed ID: 36670497
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of gene mutation in lung cancer based on deep learning and histomorphology analysis].
Wang Q; Shen Q; Zhang Z; Cai C; Lu H; Zhou X; Xu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Feb; 37(1):10-18. PubMed ID: 32096372
[TBL] [Abstract][Full Text] [Related]
5. Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis.
Zou B; Lee VHF; Yan H
BMC Bioinformatics; 2018 Mar; 19(1):88. PubMed ID: 29514601
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Whiting P; van Asselt T; Ramaekers B; Armstrong N; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2014 May; 18(32):1-166. PubMed ID: 24827857
[TBL] [Abstract][Full Text] [Related]
7. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract][Full Text] [Related]
8. [Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations].
Jiang L; Lin Z; Li N; Jiang J; Lu C; Du S; Zhang J; Wang Y; Chen J; Gong P
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):623-631. PubMed ID: 34455737
[TBL] [Abstract][Full Text] [Related]
9. Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach.
Salto-Tellez M; Tsao MS; Shih JY; Thongprasert S; Lu S; Chang GC; Au JS; Chou TY; Lee JS; Shi YK; Radzi A; Kang JH; Kim SW; Tan SY; Yang JC
J Thorac Oncol; 2011 Oct; 6(10):1663-9. PubMed ID: 21869714
[TBL] [Abstract][Full Text] [Related]
10. Machine learning based personalized drug response prediction for lung cancer patients.
Qureshi R; Basit SA; Shamsi JA; Fan X; Nawaz M; Yan H; Alam T
Sci Rep; 2022 Nov; 12(1):18935. PubMed ID: 36344580
[TBL] [Abstract][Full Text] [Related]
11. Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study.
Wang S; Yu H; Gan Y; Wu Z; Li E; Li X; Cao J; Zhu Y; Wang L; Deng H; Xie M; Wang Y; Ma X; Liu D; Chen B; Tian P; Qiu Z; Xian J; Ren J; Wang K; Wei W; Xie F; Li Z; Wang Q; Xue X; Liu Z; Shi J; Li W; Tian J
Lancet Digit Health; 2022 May; 4(5):e309-e319. PubMed ID: 35341713
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
[TBL] [Abstract][Full Text] [Related]
13. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
Gelatti ACZ; Drilon A; Santini FC
Lung Cancer; 2019 Nov; 137():113-122. PubMed ID: 31568888
[TBL] [Abstract][Full Text] [Related]
15. The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations.
Hernandez L; Young M
J Manag Care Spec Pharm; 2023 Feb; 29(2):172-186. PubMed ID: 36373869
[No Abstract] [Full Text] [Related]
16. Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy.
Sari M; Aydiner A
J Cancer Res Ther; 2020; 16(1):132-138. PubMed ID: 32362623
[TBL] [Abstract][Full Text] [Related]
17. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
Haim O; Abramov S; Shofty B; Fanizzi C; DiMeco F; Avisdris N; Ram Z; Artzi M; Grossman R
J Neurooncol; 2022 Mar; 157(1):63-69. PubMed ID: 35119589
[TBL] [Abstract][Full Text] [Related]
18. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance.
Jotte RM; Spigel DR
Cancer Med; 2015 Nov; 4(11):1621-32. PubMed ID: 26310719
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.
Le NQK; Kha QH; Nguyen VH; Chen YC; Cheng SJ; Chen CY
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502160
[TBL] [Abstract][Full Text] [Related]
20. Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Robichaux JP; Le X; Vijayan RSK; Hicks JK; Heeke S; Elamin YY; Lin HY; Udagawa H; Skoulidis F; Tran H; Varghese S; He J; Zhang F; Nilsson MB; Hu L; Poteete A; Rinsurongkawong W; Zhang X; Ren C; Liu X; Hong L; Zhang J; Diao L; Madison R; Schrock AB; Saam J; Raymond V; Fang B; Wang J; Ha MJ; Cross JB; Gray JE; Heymach JV
Nature; 2021 Sep; 597(7878):732-737. PubMed ID: 34526717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
